The pathway regulated by PD-1 inhibits several transcription factors, such as the nuclear factor-κB (NF-κB) and the nuclear factor of activated T cells (NFAT); this pathway is triggered when PD-1 is engaged by PD-L1, which is usually overexpressed in tumor cells [6,8,9]. This evidence concerns the gene PDCD1 and neoplasm.